We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.91B
1-Year Est. Return 31.61%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+31.61%
3 Year Est. Return
+70.8%
5 Year Est. Return
+92.39%
10 Year Est. Return
+369.61%
AUM
$1.02B
AUM Growth
+$4.67M
Cap. Flow
+$2.09M
Cap. Flow %
0.21%
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6

Top Buys

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$880K
2
WLY icon
John Wiley & Sons Class A
WLY
+$642K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$597K
4
USB icon
US Bancorp
USB
+$563K
5
CVX icon
Chevron
CVX
+$444K

Top Sells

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$566K
2
SYK icon
Stryker
SYK
+$501K
3
MSFT icon
Microsoft
MSFT
+$415K
4
ARRY
Array Biopharma Inc
ARRY
+$369K
5
GS icon
Goldman Sachs
GS
+$321K

Sector Composition

Rank Sector Weight
1 Technology 26.47%
2 Healthcare 17.23%
3 Consumer Staples 12.12%
4 Financials 11.97%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAT icon
126
Waters Corp
WAT
$41B
$536K 0.05%
2,400
– –
CMCSA icon
127
Comcast
CMCSA
$86.7B
$529K 0.05%
11,736
-822
-7% -$36.4K
DOW icon
128
Dow Inc
DOW
$21.6B
$514K 0.05%
10,786
– –
NBL
129
DELISTED
Noble Energy, Inc.
NBL
$505K 0.05%
22,469
– –
ALXN
130
DELISTED
Alexion Pharmaceuticals
ALXN
$504K 0.05%
5,145
+685
+15% +$77.2K
INTC icon
131
Intel
INTC
$513B
$454K 0.04%
8,817
– –
HUBB icon
132
Hubbell
HUBB
$23.2B
$441K 0.04%
3,358
-123
-4% -$15.9K
MO icon
133
Altria Group
MO
$117B
$422K 0.04%
10,322
-250
-2% -$11.5K
CSCO icon
134
Cisco
CSCO
$434B
$412K 0.04%
8,335
– –
VZ icon
135
Verizon
VZ
$214B
$408K 0.04%
6,766
– –
ABBV icon
136
AbbVie
ABBV
$465B
$402K 0.04%
5,311
+350
+7% +$24K
FTV icon
137
Fortive
FTV
$17B
$402K 0.04%
9,286
-397
-4% -$18.3K
KHC icon
138
Kraft Heinz
KHC
$29.3B
$394K 0.04%
14,107
– –
ORCL icon
139
Oracle
ORCL
$404B
$376K 0.04%
6,838
+350
+5% +$19.3K
SLB icon
140
SLB Ltd
SLB
$80.4B
$348K 0.03%
10,198
– –
AMT icon
141
American Tower
AMT
$82.8B
$344K 0.03%
1,557
– –
WBA
142
DELISTED
Walgreens Boots Alliance
WBA
$335K 0.03%
6,052
– –
SON icon
143
Sonoco
SON
$4.77B
$327K 0.03%
5,625
-300
-5% -$17.9K
KMX icon
144
CarMax
KMX
$8.49B
$324K 0.03%
3,682
– –
D icon
145
Dominion Energy
D
$56.2B
$319K 0.03%
3,931
– –
NVO
146
Novo Nordisk
NVO
$188B
$319K 0.03%
12,334
– –
WFC icon
147
Wells Fargo
WFC
$271B
$308K 0.03%
6,109
-2,000
-25% -$94.2K
EPD icon
148
Enterprise Products Partners
EPD
$83.8B
$300K 0.03%
10,496
– –
CPB icon
149
Campbell Soup
CPB
$6.37B
$299K 0.03%
6,367
– –
WST icon
150
West Pharmaceutical
WST
$25.7B
$296K 0.03%
2,088
– –
4 5
6
7 8

Similar funds

CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return
DC
Dendur Capital New York $1.9B AUM 46.69% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
PP
PDT Partners New York $1.9B AUM 71.86% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return

Grandfield & Dodd's Q3 2019 Portfolio in Review

As of Q3 2019, Grandfield & Dodd held 183 positions worth $1.02B, up 0.46% from $1.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.4%. Grandfield & Dodd opened 2 new positions and exited 6, leaving the 183-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Grandfield & Dodd's largest Q3 2019 buy was iShares Russell 1000 Growth ETF: 5,832 shares worth $233K.
  • Grandfield & Dodd added most to Blackbaud in Q3 2019, an estimated $880K increase.
  • Grandfield & Dodd's biggest Q3 2019 reduction was Amdocs, cutting an estimated $566K.
  • Grandfield & Dodd fully exited Array Biopharma Inc in Q3 2019, selling an estimated $369K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.02B portfolio in Q3 2019.
  • Grandfield & Dodd opened 2 new positions and closed 6 in Q3 2019.
  • Grandfield & Dodd's portfolio value rose 0.46% quarter-over-quarter to $1.02B.

Based on Grandfield & Dodd's 13F filing for Q3 2019, filed 30 Oct 2019.